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Abstract 
 
Nasopharyngeal Carcinoma (NPC) is a cancer that occurs in nasopharynx which is associated with Epstein-Barr Virus (EBV). Mutation 
agents in nasopharyngeal neoplasms occur because of EBV infection. Transformation of B-cells due to EBV causes hormone imbalance 
in lymphoid cells or nasopharyngeal epithelial tissue. Rates of EBV infection have been shown to be prognostic to NPC. The basic level 
of EBV DNA can be used for stratification prognosis, with higher titers showing greater disease severity and worse outcomes. With 
mathematical models, there is a correlation between the increase in Epstein-Barr Virus and the increase in Invasive Carcinoma Cells or 
increase in Nasopharyngeal Carcinoma Cells. 
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INTRODUCTION 
 
The body consists of trillions of living cells. The normal 
cells of the body grow, divide, and die regularly. During 
the early years of a person's life, normal cells divide 
faster to allow people to grow. Once a person becomes 
an adult, most cells divide only to replace obsolete or 
dead cells to repair the lesion. (Shah et al., 2012) 
Cancer begins when cells in the body part grow out 
of control. There are many types of cancer, but they all 
start because of the absence of abnormal cell growth 
control. (Mimi and Yuan et al., 2002) 
Nasopharyngeal carcinoma (NPC) is a malignancy 
derived from the epithelium or mucosa and crypts that 
line the surface of the nasopharynx (Morrison, 2004); 
(Kong et al., 2010); (Lin et al., 2003). In Indonesia, 
nasopharyngeal carcinoma are most commonly found 
among malignant tumors in head and neck and age most 
who suffer is age 40 years and above (Adham et al., 
2012); (Fachiroh et al, 2004); (Stevens, 2005). 
Prevalence of nasopharyngeal carcinoma in Indonesia is 
4.7 / 100.000 population per year (Nurhantari et al., 
2003). 
The study was first written Old et al. (1966) on the 
link between Epstein-Barr Virus (EBV) and NPC using 
metallic assays hybridization dan anticomplement 
immunoflourescent (ACID). About 90% of the adult 
population has undifferentiated nasopharyngeal 
carcinomas (UNPC) are positive of EBV with a blood 
test (Zeng and Zeng, 2010). In Wu et al. (2003) person 
with positive EBV, the cancer will be faster than EBV 
negative. Many studies indicate that UNPC is always 
positive EBV (Lo and Huang, 2004). EBV DNA can be 
identified nasopharynx that the patient has NPC disease 
(Sheen et al., 1998). In other words, EBV is one cause of 
the development of nasopharyngeal cancer.  
Researchers in the medical field have created 
categories for the development of abnormal cells. 
Categorization of nasopharyngeal cancer is introduced 
by the World Health Organization (WHO) (Zeng and 
Zeng, 2010). Several methods of cancer treatment have 
also been developed. The development of normal 
nasopharynx epithelium to nasopharyngeal cancer is 
also known as tumorigenesis model for EBV-associated 
nasopharyngeal carcinoma at the cellular level. On the 
other hand, mathematically the development of cells 
from normal cells, then infected with the EBV, until 
then into cancer cells can be modeled as a model of 
dynamics. The modeling will be able to see the 
dynamics of the development of normal cells to become 
cancer cells and estimated how fast the cancer cells 
spread. Although the development of nasopharyngeal 
cancer is not only affected by EBV infection, but 
because EBV infection is more dominant than other 
factors, factors other than temporary EBV infection may 
be neglected in mathematical modeling (Aryati et al., 
2016). 
 
Nasopharyngeal Carcinoma 
Nasopharyngeal Carcinoma is a very dangerous 
abnormality nasopharynx epithelium. The main one of 
these cancers is endemic and some areas are very low 
incidence of this cancer (Lu et al., 2010); (Wang et al., 
2011). 
The hypothesis about the cause of nasopharyngeal 
cancer began in the early 20th century, first proposed by 
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Jackson in 1901, which proposed the hypothesis that 
dust irritation in cork workers would damage airway 
epithelia. Since then the pathogenesis of nasopharyngeal 
cancer has been intensively studied, in particular aimed 
at geographical features and racial variations. In recent 
years many environmental and biological factors have 
shown a link between the risk of nasopharyngeal cancer 
and recent research results suggest the role of genetic 
and viral factors in the progression of this disease 
(McDermott et al., 2001). 
There are three types of NPC, these are based on 
cancer cells under a microscope: Keratinizing squamous 
cell carcinoma, Non-keratinizing differentiated 
carcinoma and Undifferentiated carcinoma. Each type is 
different from one country to another. In South China, 
NPC are generally found to be type Undifferentiated.  
Different cancers are caused by different factors. The 
factors that cause nasopharyngeal cancer differ from 
everyone. Some of the factors can be changed, such as 
smoking, on the contrary the factors that cause due to 
age, family history of cancer, cannot be changed. 
However, these factors do not tell much about 
nasopharyngeal cancer. Many people have this disease 
but do not know the cause. Epstein-Barr virus (EBV) 
infection combined with frequent exposure to 
environmental carcinogenic co-factors is suggested to 
cause NPC development (Adham et al., 2012).  
 
Ebstein-Bar Virus (EBV)  
Ebstein-Barr Virus (EBV) or other name human 
herpesvirus 4 (HHV-4), belongs to the family: herpes 
virus Subfamily: Gammaherpesvirinae (EBV), Genus: 
Lymphocryptovirus (EBV) (Hendrix, 2013). The adult 
EBV particle has a diameter of 120-180 nm and wraps 
the lipid bilayer. The primary target of cells for EBV 
infection is B lymphocytes (B-cells) (Hendrix, 2013). 
Incubation period of virus 7 to 14 days for children and 
adolescents is about 30 to 50 days for adults (Bale, 
1999). 
The particles caused by this virus are transmitted 
through saliva and are often incubated in 15 years during 
their life without symptoms. 
Seroepidemiologic studies indicate that more than 
90% of people in the world are infected with EBV 
(Hendrix, 2013). 
Characteristics and mechanism of Nasopharyngeal 
Carcinoma 
DNA is a chemical in every human cell that makes 
genes, a clue to how cells function. DNA usually looks 
like a parent because they are the source of our DNA. 
DNA affects more than how people see it. Some genes 
contain instructions to control when cells grow and 
divide into new cells. Viruses such as EBV also contain 
DNA (Chua et al., 2016). When cells are infected with 
viruses, viral DNA may be mixed with normal human 
DNA. EBV DNA can instruct nasopharyngeal cells to 
divide and grow in an abnormal way (Chong et al., 
1996). 
EBV-infected cells express several specific viral 
antigens for each period of infection (Lin et al., 1997). 
EBV latent infection is characterized by expression of 
Epstein-Barr Virus Nuclear Antigen-1 (EBNA-1) and 
EBNA-2, Latent Protein (LMP) Membrane, and Epstein 
Barr virus Encoded small RNAs (EBER) (Zheng et al., 
2007). These proteins can interact or have homology 
with various body proteins such as antiapoptosis 
proteins, cytokines and signal transduction. Viral 
proteins play a role in maintaining the EBV genome in 
B-cells. The EBV is detected in all periods of latent 
infection (Liebowitz, 1994). 
All nasopharyngeal epithelial cells are considered to 
have the same receptors so latent EBV can become 
active in EBV and infect any nasopharyngeal cells, 
without preference. In other words, it is assumed to be a 
random contact between the nasopharyngeal epithelial 
cells and the EBV virus. The population of 
nasopharyngeal cells is divided into six sub-populations, 
normal cells, dysplasia cells, EBV-infected cells, high 
dysplastic cells, invasive carcinoma cells. Normal cells 
are injured, biased due to food preservatives or tobacco. 
Wounded nasopharyngeal cells may progress to low-
plated cells, either due to a weak immune system, 
resulting in no improvement in genes or apoptosis. The 
EBV-infected cells are infected dysplasia cells, causing 
the cell to become infected. The EBV-infected that do 
not occur apoptosis may progress into high dysplastic 
cells. The high dysplastic cells may progress to invasive 
carcinoma cells. Invasive carcinoma cells can not heal, 
until it ends with the death of the patient, if no treatment. 
This process can be explained in Figure 1. 
 
 
 
 
 
Figure 1. Tumorigenesis Nasopharyngeal Carcinoma. 
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From Figure 1, system of a mathematical model 
(Aryati et al., 2016) in equations (1) - (6) as follows: 
 
1 1
dN
a N d N
dt
    (1) 
2 2
dD
a D N DV d D
dt
      (2) 
3 3
dI
a I DV I d I
dt
      (3) 
4 4
H
H H H
dD
a D I D d D
dt
      (4) 
5 5H
dC
a C D d C
dt
    (5) 
3 6
dV
ea I d V
dt
   (6) 
 
where, 
 
N  : Subpopulation of Normal Cells 
D  : Subpopulation of Dysplasia Cells 
I  : Subpopulation of EBV Infected Cells 
HD  : Subpopulation of High Dysplastic Cells or 
Carcinoma In Situ (CIS) 
C  : Subpopulation of Invasive Carcinoma Cells 
V  : Subpopulation of Viruses 
1a  : The rate of proliferation of normal cells 
2a  : The rate of proliferation of dysplasia cells 
3a  : The rate of proliferation of EBV infected 
cells 
4a  : The rate of proliferation of high dysplastic 
cells 
5a  : The rate of proliferation of invasive 
carcinoma cells 
1d  : The rate of apoptosis of normal cells 
2d  : The rate of apoptosis of dysplasia cells 
3d  : The rate of apoptosis of EBV infected cells 
4d  : The rate of apoptosis of high dysplastic cells 
5d  : The rate of proliferation of invasive 
carcinoma cells 
6d  : The rate of apoptosis of EBV 
  : The rate of interaction between normal cells 
that become dysplasia cells 
  : The rate of interaction between dysplasia 
cells that become EBV-infected cells 
  : The rate of interaction between EBV-infected 
cells that become high dysplastic cells 
   The rate of interaction between high 
dysplastic cells that become invasive 
carcinoma cells 
e  : The rate of EBV increase due to the 
proliferation of EBV-infected cells. 
 
Theorem 1. The relationship between the 
Nasopharyngeal Carcinoma and Epstein-Barr Virus in 
equilibrium point is in the following equation: 
 
C V  
 
where 
  
6
3 5 5 4 4
d
ea d a d a




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. 
 
Proof. If 0
dV
dt

 
and from equation (6), then it is 
obtained 
6
3
d V
I
ea
  (7) 
If 0H
dD
dt

 
 and from equation (4), then we get 
4 4
H
I
D
d a



 
. (8) 
If 0
dC
dt

 
 and from equation (5), then we gain 
5 5
HDC
d a



. (9) 
 
If equation (8) is substituted for equation (9), then we 
have 
  5 5 4 4
I
C
d a d a



  
. (10) 
If equation (7) is substituted for equation (10), then it is 
acquired 
  
6
3 5 5 4 4
d V
C
ea d a d a



  
. ■ (11) 
 
From the theorem 1 that the relationship between 
nasopharyngeal carcinoma and Epstein-Barr Virus is 
affected by parameters: the rate of interaction between 
high dysplastic cells, the rate of interaction between 
EBV-infected cells that become high dysplastic cells, 
the rate of apoptosis of EBV, the rate of proliferation of 
EBV infected cells, the rate of proliferation of EBV 
infected cells, the rate of proliferation of invasive 
carcinoma cells, the rate of proliferation of invasive 
carcinoma cells, the rate of apoptosis of high dysplastic 
cells, and the rate of proliferation of high dysplastic 
cells. If Table 1 is included in equation 11 obtained 
3.3C V . 
 
Simulation 
In this section, we will discuss numerical simulations 
and medical interpretations of mathematical models of 
Nasopharyngeal Carcinoma. 
Figure 2 shows a trajectory diagram for variables V 
and C. Within 100 days, variables V and C occur at the 
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beginning of the occurrence of NPC. Within the first 
100 days the Epstein-Barr Virus value was 4.92 virus / 
mm2 and the invasive carcinoma cells value was 3.807 
cell/mm2. At the stage of the formation of invasive 
carcinoma cells are things that need attention, because 
remember this cancer is a type that is malignant. The 
earlier the cancer is very related to the treatment process 
and is related to the survival of NPC sufferers.  
Figure 3 shows a portrait diagram of the phase 
between Epstein-Barr Virus and Invasive Carcinoma 
Cells. There is a correlation between the increase in 
Epstein-Barr Virus and Invasive Carcinoma Cells. This 
has an interpretation that NPC occurs because of an 
increase in EBV (Hu, 1996).  
 
Table 1. The parameter values of the nasopharyngeal carcinoma 
mathematical model. 
 
No. Parameter Value Unit Reference 
1. 1a  13 cell mm
–3 day–1  (Huynh, 2010) 
2. 2a  0,001 
day–1 Estimation 
3. 3a  0.0138 
day–1 (Huynh, 2010) 
4. 4a  0.04 
day–1 (Aryati et al., 2016) 
5. 5a  0.0138 
day–1 (Aryati et al., 2016) 
6. 1d  1.0412 
day–1 (Aryati et al., 2016) 
7. 2d  0.02 
day–1 (Aryati et al., 2016) 
8. 3d  0.0288 
day–1 (Huynh, 2010) 
9. 4d  0.1152 
day–1 (Aryati et al., 2016) 
10. 5d  0.0188 
day–1 (Aryati et al., 2016) 
11 6d  
0.1152 day
–1 (Huynh, 2010) 
12. e  2 day–1 (Aryati et al., 2016) 
13. 
 
0.05 day–1 (Aryati et al., 2016) 
14. 
 
1 day
–1 (Aryati et al., 2016) 
15.   0.0082 day–1 (Aryati et al., 2016) 
16.   0.07 day–1 (Aryati et al., 2016) 
 
 
 
Figure 2. Trajectory diagram of Epstein-Barr Virus and invasive 
carcinoma cells in the first 100 days of NPC development. 
 
 
Figure 3. Portrait projection of Epstein-Barr Virus and invasive 
carcinoma cells in the first 100 days of NPC development. 
 
 
 
CONCLUSION 
 
The relationship between the Nasopharyngeal 
Carcinoma and Epstein-Barr Virus is directly 
proportional and linear. The increase in Epstein-Barr 
Virus makes an increase in invasive Carcinoma Cells by 
3.3. In the first 100 days of development of the 
Nasopharyngeal Carcinoma increasing of Epstein-Barr 
Virus are followed Invasive Carcinoma Cells. 
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